Novo Nordisk rolls out authorized insulin generics, following similar moves by Lilly, Sanofi

6th September 2019 Uncategorised 0

Following Eli Lilly and Sanofi, Novo Nordisk has become the last of the Big Three insulin makers to have come up with a plan to lower its insulin prices amid mounting criticism over their high costs in the U.S.

More: Novo Nordisk rolls out authorized insulin generics, following similar moves by Lilly, Sanofi
Source: fierce